ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden · Delayed Price · Currency is SEK 1.445
-0.015 (-1.03%)
Aug 13, 2026, 5:24 PM CET
STO:EXPRS2 Market Cap
STO:EXPRS2 has a market cap or net worth of 34.32 million as of August 13, 2026. Its market cap has decreased by -48.77% in one year.
Market Cap
34.32M
Enterprise Value
13.72M
Revenue
16.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.45
ChartMarket Cap Chart
Since July 29, 2016, STO:EXPRS2's market cap has decreased from 117.71M to 34.32M, a decrease of -70.85%. That is a compound annual growth rate of -11.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 34.32M | -38.86% |
| Dec 30, 2025 | 56.13M | 29.73% |
| Dec 30, 2024 | 43.27M | -60.11% |
| Dec 29, 2023 | 108.46M | -82.55% |
| Dec 30, 2022 | 621.64M | -45.72% |
| Dec 30, 2021 | 1.15B | 280.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascelia Pharma AB | 77.98M |
| Spago Nanomedical AB | 76.08M |
| AcouSort AB | 71.53M |
| Pila Pharma AB | 61.44M |
| Disruptive Pharma AB | 57.61M |
| 2cureX AB | 51.56M |
| Modus Therapeutics Holding AB | 48.65M |
| Fluicell AB | 40.11M |